BioPorto A/S provided earnings guidance for 2024. For the period, the company expects total revenue target of DKK 40 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.095 DKK | +5.70% |
|
+24.41% | +0.24% |
Jun. 18 | BioPorto to Raise DKK81 Million to Fund Clinical Trials | MT |
May. 30 | BioPorto A/S Appoints Niels Høy Nielsen as Member of the Executive Management Team, Effective August 1, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.24% | 108M | |
-10.54% | 11.41B | |
-11.02% | 7.53B | |
+30.85% | 5.62B | |
-16.28% | 3.82B | |
+8.39% | 2.6B | |
-64.67% | 2.37B | |
-9.66% | 2.26B | |
+24.87% | 2.16B | |
-12.06% | 1.71B |
- Stock Market
- Equities
- BIOPOR Stock
- News BioPorto A/S
- Bioporto A/S Provides Earnings Guidance for 2024